Company Overview of Ciba-Geigy AG
Ciba-Geigy AG was acquired by Novartis AG. Ciba-Geigy merged with Sandoz to form Novartis in March 1996. The Specialty Chemicals division of Ciba was spun-off from the company. The formation of Novartis was executed as a tax free combination, whereby Ciba and Sandoz were absorbed by the new legal entity. The transaction was structured as a merger of equals based on an exchange of shares, providing Sandoz shareholders 55% and Ciba shareholders 45% of the shares of the new company. Ciba with 1995 sales of CHF 20.7 bio is a leading worldwide biological and chemicals group, headquartered in Basel, dedicated to satisfying needs in healthcare, agriculture and industry.
41 61 636 11 11
Key Executives for Ciba-Geigy AG
Ciba-Geigy AG does not have any Key Executives recorded.
Similar Private Companies By Industry
|Aaqius & Aaqius SA||Europe|
|Alcopor Holding AG||Europe|
|Alfa Klebstoffe AG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Ciba-Geigy AG, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.